Raymond James lowered the firm’s price target on Johnson & Johnson to $165 from $170 and keeps an Outperform rating on the shares.

J&J’s 2025 results will be the launching point for its guidance of 5%-7% revenue growth for 2025-30, which is still well ...

Magic Johnson is now worth an estimated $1.2 billion. His career earnings as a basketball player was $40 million. The magic? He says it comes from—of course—teaming up.

The founder, managing principal, and chief investment officer of AQR Capital Management, Cliff Asness is a well-known name in ...

Johnson & Johnson (NYSE: JNJ) stock is up 1.8% in the five days after the company announced its $14.6 billion acquisition of ...

Johnson & Johnson agreed to acquire Intra-Cellular Therapies Inc., a company focused on treatments for central nervous system ...

Intra-Cellular Therapies makes Caplyta, a once-daily pill for adults with schizophrenia and bipolar-related depression ...

Johnson & Johnson agreed to acquire Intra-Cellular Therapies Inc., a company focused on treatments for central nervous system ...

Johnson & Johnson (J&J) has agreed to pay $132 per share to acquire Intra-Cellular Therapies Inc. in a deal valued at about $14.6 billion, taking ownership of Caplyta (lumateperone), a once-daily oral ...

New Brunswick-based Johnson & Johnson and Bedminster-based Intra-Cellular Therapies, Inc. have entered into a definitive agreement ...

Political novice Renard Johnson's business acumen, community work brings new leadership style to mayor's office.

Will Dwayne "The Rock" Johnson make an appearance at WrestleMania 41? This WWE Hall of Famer believes he's a lock for Las ...